4635 studies found for:    Lung Diseases, Obstructive
Show Display Options
Rank Status Study
21 Completed
Has Results
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: AZD1236;   Drug: Placebo
22 Completed
Has Results
A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
Conditions: Asthma;   Coronary Artery Disease;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Regadenoson;   Drug: Placebo
23 Completed
Has Results
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone propionate/salmeterol combination product;   Drug: Salmeterol;   Drug: Placebo
24 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate combination;   Drug: Other maintenance Treatments (OMT)
25 Completed
Has Results
Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD4818;   Drug: Placebo
26 Completed A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Respiratory Tract Diseases;   Chronic Obstructive Airway Disease;   COPD
Interventions: Drug: placebo;   Drug: active comparator;   Drug: PF-03635659
27 Completed
Has Results
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744);   Drug: Formoterol;   Drug: Placebo
28 Completed
Has Results
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744);   Drug: Formoterol;   Drug: Placebo
29 Completed A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Lung Diseases, Obstructive
Interventions: Drug: PF-00610355;   Drug: PF - 00610355;   Drug: PF- 00610355;   Drug: Placebo;   Drug: Salmeterol
30 Completed
Has Results
A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Symbicort Turbuhaler (Budesonide/formoterol);   Drug: Drug: any available COPD treatment; investigator to decide
31 Recruiting Is COPD a Risk Factor for Cardiovascular Disease?
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
32 Active, not recruiting Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine
33 Not yet recruiting Treatment in Patients Hospitalized With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
34 Completed Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Formoterol Fumarate
35 Active, not recruiting An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: JNJ 49095397;   Drug: Placebo
36 Active, not recruiting Metformin in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Metformin;   Drug: Placebo
37 Active, not recruiting Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Emphysema;   Bronchitis, Chronic
Intervention:
38 Completed
Has Results
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237 100 µg;   Drug: Placebo;   Drug: NVA237 200 µg
39 Completed PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Pulmonary Emphysema;   Chronic Bronchitis
Interventions: Drug: PROCHYMAL™;   Drug: Placebo
40 Completed
Has Results
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: aclidinium bromide

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years